EGFR and lung carcinoma: This phenomenon has been experimentally confirmed in lung cancer research: Hill et al.’s184 study demonstrated that EGFR and KRAS‐driven mutations inherently exist in normal AT2 cells, but these cells do not develop into tumours unless they are reprogrammed into a progenitor‐like cell state.